Insights into Novel Drug Targets in Mycobacterium tuberculosis: Where Do We Stand and Where Do We Go from Here?

The key players in the arsenal of combating TB; reviewing the lead InhA inhibitors

1,8-Diaminonaphthalene-derived pharmacophore as potent anti-MRSA with dual DNA gyrase and topoisomerase IV inhibition

The Recent Outstanding Medicinal Activity of 2- (Aryl/Heteroaryl) Thiazolidine-4-One Derivatives as Antituberculous Agents

Geometrical and Topological Descriptors for Activities Modeling of some Potent Inhibitors against Mycobacterium Tuberculosis: A Genetic Functional Approach

DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY PROFILING STUDY OF IMIDAZOLINONE-BASED HYDRAZONES AS POTENTIAL MULTITARGET ANTIMYCOBACTERIAL AGENTS

Synthesis, In Vitro Biological Investigation, and In Silico Analysis of Pyrazole-Based Derivatives as Multi-target Agents

Discovery of Novel N-Acetylpyrazolines as Microtubule Inhibitors: Design, Synthesis, Anticancer Evaluation, and Molecular Docking Study

Design, Sequential Synthesis, Kinase Inhibitors Comparative Docking, MD Simulations, 99mTc-Coupling and In-Vivo Studies of Novel Pyrazolopyrimidine Derivatives

Imidazo[4,5-b]phenazines as Dual Topoisomerase I/IIα Inhibitors: Design, Synthesis, Biological Evaluation and Molecular Docking